KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Quest Diagnostics (DGX) Net Margin (2016 - 2025)

Quest Diagnostics (DGX) has disclosed Net Margin for 17 consecutive years, with 7.59% as the latest value for Q4 2025.

  • Quarterly Net Margin rose 11.0% to 7.59% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 7.8% through Dec 2025, up 11.0% year-over-year, with the annual reading at 8.77% for FY2025, 1.0% down from the prior year.
  • Net Margin hit 7.59% in Q4 2025 for Quest Diagnostics, roughly flat from 7.6% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 28.27% in Q2 2021 to a low of 3.26% in Q4 2022.
  • Historically, Net Margin has averaged 9.98% across 5 years, with a median of 8.4% in 2023.
  • Biggest five-year swings in Net Margin: surged 3101bps in 2021 and later plummeted -1984bps in 2022.
  • Year by year, Net Margin stood at 12.72% in 2021, then plummeted by -74bps to 3.26% in 2022, then surged by 117bps to 7.08% in 2023, then grew by 6bps to 7.48% in 2024, then rose by 2bps to 7.59% in 2025.
  • Business Quant data shows Net Margin for DGX at 7.59% in Q4 2025, 7.6% in Q3 2025, and 9.05% in Q2 2025.